Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1992 Apr;50(4):852–858.

Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.

Y Tatuch 1, J Christodoulou 1, A Feigenbaum 1, J T Clarke 1, J Wherret 1, C Smith 1, N Rudd 1, R Petrova-Benedict 1, B H Robinson 1
PMCID: PMC1682643  PMID: 1550128

Abstract

A female infant showing lacticacidemia, hypotonia, and neurodegenerative disease died at 7 mo of age. Autopsy revealed lesions typical of Leigh disease, both in the basal ganglia and in the brain stem. A maternal aunt and uncle died 1 year and 5 mo, respectively, after following a similar clinical course, while another uncle, presently 33 years of age, has retinitis pigmentosa and ataxia and is mentally retarded. PCR restriction-digest analysis of mtDNA isolated from the proband revealed a T-to-G change at position 8993, creating a new AvaI restriction site. The mutation present in the ATP 6 gene results in the substitution of an arginine residue for a leucine. The indexed patient had greater than 95% abnormal mtDNA in her skin fibroblasts, brain, kidney, and liver tissues, as measured by laser densitometry. The maternal aunt who died at age 1 year had greater than 95% abnormal mtDNA in her lymphoblasts. The uncle with retinitis pigmentosa had 78% and 79% abnormal mtDNA in his skin fibroblasts and lymphoblasts, respectively, while an asymptomatic maternal aunt and her son had no trace of this mutation. The mother of the index case had 71% and 39% abnormal mtDNA in her skin fibroblasts and lymphoblasts, respectively, showing that the heteroplasmy can be variable, on a tissue-specific basis, within one individual. This shows that mtDNA mutations at 8993 can produce the clinical phenotype of Leigh disease in addition to the phenotype of ataxia and retinitis pigmentosa described by Holt et al.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
852

Images in this article

855Figure 3
on p.855
856Figure 4
on p.856
856Figure 5
on p.856

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyer P. D. A perspective of the binding change mechanism for ATP synthesis. FASEB J. 1989 Aug;3(10):2164–2178. doi: 10.1096/fasebj.3.10.2526771. [DOI] [PubMed] [Google Scholar]
  2. Cox G. B., Fimmel A. L., Gibson F., Hatch L. The mechanism of ATP synthase: a reassessment of the functions of the b and a subunits. Biochim Biophys Acta. 1986 Apr 2;849(1):62–69. doi: 10.1016/0005-2728(86)90096-4. [DOI] [PubMed] [Google Scholar]
  3. DiMauro S., Servidei S., Zeviani M., DiRocco M., DeVivo D. C., DiDonato S., Uziel G., Berry K., Hoganson G., Johnsen S. D. Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol. 1987 Oct;22(4):498–506. doi: 10.1002/ana.410220409. [DOI] [PubMed] [Google Scholar]
  4. Farrell L. B., Nagley P. Human liver cDNA clones encoding proteolipid subunit 9 of the mitochondrial ATPase complex. Biochem Biophys Res Commun. 1987 May 14;144(3):1257–1264. doi: 10.1016/0006-291x(87)91446-x. [DOI] [PubMed] [Google Scholar]
  5. Fujii T., Ito M., Okuno T., Mutoh K., Nishikomori R., Mikawa H. Complex I (reduced nicotinamide-adenine dinucleotide-coenzyme Q reductase) deficiency in two patients with probable Leigh syndrome. J Pediatr. 1990 Jan;116(1):84–87. doi: 10.1016/s0022-3476(05)81650-6. [DOI] [PubMed] [Google Scholar]
  6. Glerum D. M., Yanamura W., Capaldi R. A., Robinson B. H. Characterization of cytochrome-c oxidase mutants in human fibroblasts. FEBS Lett. 1988 Aug 15;236(1):100–104. doi: 10.1016/0014-5793(88)80293-x. [DOI] [PubMed] [Google Scholar]
  7. Goto Y., Nonaka I., Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990 Dec 13;348(6302):651–653. doi: 10.1038/348651a0. [DOI] [PubMed] [Google Scholar]
  8. Holt I. J., Harding A. E., Petty R. K., Morgan-Hughes J. A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 1990 Mar;46(3):428–433. [PMC free article] [PubMed] [Google Scholar]
  9. Joshi S., Pringle M. J. ATP synthase complex from bovine heart mitochondria. Passive H+ conduction through mitochondrial coupling factor 6-depleted F0 complexes. J Biol Chem. 1989 Sep 15;264(26):15548–15551. [PubMed] [Google Scholar]
  10. Lott M. T., Voljavec A. S., Wallace D. C. Variable genotype of Leber's hereditary optic neuropathy patients. Am J Ophthalmol. 1990 Jun 15;109(6):625–631. doi: 10.1016/s0002-9394(14)72429-8. [DOI] [PubMed] [Google Scholar]
  11. Papa S., Guerrieri F., Zanotti F., Fiermonte M., Capozza G., Jirillo E. The gamma subunit of F1 and the PVP protein of F0 (F0I) are components of the gate of the mitochondrial F0F1 H(+)-ATP synthase. FEBS Lett. 1990 Oct 15;272(1-2):117–120. doi: 10.1016/0014-5793(90)80462-r. [DOI] [PubMed] [Google Scholar]
  12. Pincus J. H., Solitare G. B., Cooper J. R. Thiamine triphosphate levels and histopathology. Correlation in Leigh disease. Arch Neurol. 1976 Nov;33(11):759–763. doi: 10.1001/archneur.1976.00500110027005. [DOI] [PubMed] [Google Scholar]
  13. Poulton J., Turnbull D. M., Mehta A. B., Wilson J., Gardiner R. M. Restriction enzyme analysis of the mitochondrial genome in mitochondrial myopathy. J Med Genet. 1988 Sep;25(9):600–605. doi: 10.1136/jmg.25.9.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Robinson B. H., Glerum D. M., Chow W., Petrova-Benedict R., Lightowlers R., Capaldi R. The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lacticacidemia. Pediatr Res. 1990 Nov;28(5):549–555. doi: 10.1203/00006450-199011000-00027. [DOI] [PubMed] [Google Scholar]
  15. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  16. Shoffner J. M., Lott M. T., Lezza A. M., Seibel P., Ballinger S. W., Wallace D. C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell. 1990 Jun 15;61(6):931–937. doi: 10.1016/0092-8674(90)90059-n. [DOI] [PubMed] [Google Scholar]
  17. Soderberg K., Nissinen E., Bakay B., Scheffler I. E. The energy charge in wild-type and respiration-deficient Chinese hamster cell mutants. J Cell Physiol. 1980 Apr;103(1):169–172. doi: 10.1002/jcp.1041030121. [DOI] [PubMed] [Google Scholar]
  18. Wallace D. C., Singh G., Lott M. T., Hodge J. A., Schurr T. G., Lezza A. M., Elsas L. J., 2nd, Nikoskelainen E. K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988 Dec 9;242(4884):1427–1430. doi: 10.1126/science.3201231. [DOI] [PubMed] [Google Scholar]
  19. Wexler I. D., Kerr D. S., Ho L., Lusk M. M., Pepin R. A., Javed A. A., Mole J. E., Jesse B. W., Thekkumkara T. J., Pons G. Heterogeneous expression of protein and mRNA in pyruvate dehydrogenase deficiency. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7336–7340. doi: 10.1073/pnas.85.19.7336. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES